Dr. Mark Hamilton is a native of Austin Texas. His undergraduate education was at Austin College in Sherman, Texas, where he graduated summa cum laude with majors in biology and English literature and minors in chemistry and anthropology. Mark learned a love for science and medicine in college leading to the pursuit of a combined MD/PhD at Baylor College of Medicine. For his PhD work, Mark worked in The Cancer Genome Atlas project using genomic sequencing technologies to understand how microRNAs function in cancer. Mark subsequently joined Stanford’s Translational Investigator Program which combines residency in Internal Medicine and fellowship in Hematology and Oncology. Mark’s career focus is on treating leukemia and lymphoma using chimeric antigen receptor (CAR) T-cell therapies. He is especially interested in using genomic sequencing technologies to understand how CAR T-cells propagate in patients and interact with the tumor to kill cancer.